Ophthalmology
Collaborating to restore vision and improve lives
The eye is one of the most complex organs in the human body, transmitting visual signals to the brain so we can perceive the world around us. Consequently, ophthalmology clinical trials are highly specialized, requiring intimate knowledge of the patient and caregiver experience, deep relationships with quality research sites as well as technical skills for visual assessment, ocular imaging and a spectrum of treatment modalities.
Since 2019, Syneos Health has executed 400+ ophthalmology projects and since 2010, developed and commercialized 50+ approved eye care products, making us a leading ophthalmology contract research organization providing clinical development and commercialization services for drugs, devices and diagnostics in vision care.
Experienced in specialized areas and all treatment modalities including wet AMD, genetic therapies and rare disorders
Since 2019:
- 37 Wet AMD Studies
- 26 Genetic Medicine (Gene, Cell, RNA/DNA Therapies) Projects
- 43 Orphan & Rare Disease Projects
- 18 Device & Combinations
- 12 Pediatric Projects
- 21 Biosimilar Projects
Engage with Us
We’ll See You at ARVO 2025
Syneos Health will be at ARVO 2025! Find us at booth #1841 or schedule a meeting to learn how we can elevate your ophthalmology clinical development.
Read our perspectives on the latest trends in ophthalmology product development.
Meet with us at another upcoming conference. See other upcoming events.
Partnering with deep scientific and therapeutic expertise
Our Ophthalmology teams consists of more than 2,300 ophthalmology-experienced staff , including 15 board-certified ophthalmologists in North America, Europe and Asia Pacific who are experts in the field and dedicated to vision research.
Operating in 80+ countries across all global regions, we have performed 122 clinical studies spanning all phases of development.
Always starting with the end in mind
At Syneos Health, we partner with a problem solving mindset to provide you with integrated scientific, clinical, regulatory, commercialization and marketing expertise.
We bring commercial insights forward into clinical development with teams that combine traditional functions (i.e., project managers, medical monitors, CRAs, and therapeutic and functional experts) with specialists in market access, study branding and patient engagement/advocacy, medical science liaisons and nurse educators.
We constantly share insights that lead to better, smarter and more innovative clinical development and commercialization solutions.
More about our range of capabilities:
Geographic Atrophy
Wet AMD
Thyroid Eye Disease
Ophthalmology Genetic Medicines
Meet Laszlo Bekesi, MD, MSc, MBA
Strong and enduring site relationships
Given our deep experience, we have developed long-lasting relationships with ophthalmology investigators at more than 500 sites around the world – allowing for efficient start-up and decreased site burden to help accelerate your timelines.
Ready to see what our Ophthalmology team can do for you?
Related Content
Looking for exclusive insight?
